All In MedTech

Device Trial Radar · NCT04437862

A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke

A Prospective, Multi-Center, Single Arm Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke: The EvaQ Study

Last checked: Nov 20, 2026Latest source record: Aug 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

121

Actual

Start

Oct 27, 2020

Primary completion

Apr 21, 2023

Study completion Aug 2, 2023

Sponsor

Lead sponsor
MIVI Neuroscience, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 18, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assess the safety and efficacy of the Q Revascularization System to remove thrombi and emboli from the neurovasculature in patients experiencing an acute ischemic stroke

Conditions

  • Acute Stroke
  • Cerebral Ischemia

Interventions

  • Q Revascularization SystemDevice

    Q Revascularization System for mechanical thrombectomy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful revascularization rateTime frame: Procedure end

1 more outcomes with a free account

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • University of South Florida

    Tampa, Florida

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.